Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation.
about
Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.Adherence to dual antiplatelet therapy after coronary stenting: a systematic review.Chronic kidney disease is associated with adverse outcomes among elderly patients taking clopidogrel after hospitalization for acute coronary syndrome.Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stentRenal insufficiency was correlated with 2-year mortality for rural female patients with ST-segment elevation acute myocardial infarction after reperfusion therapy: a multicenter, prospective study.My Interventional Drug-Eluting Stent Educational App (MyIDEA): Patient-Centered Design Methodology.Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year period.Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions.Safety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary "real-world" practiceSystematic reviews: causes of non-adherence to P2Y12 inhibitors in acute coronary syndromes and response to intervention.Prospective and systematic analysis of unexpected requests for non-cardiac surgery or other invasive procedures during the first year after drug-eluting stent implantation.Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS.Clopidogrel Therapy Discontinuation Following Drug Eluting Stent Implantation in Real World Practice in IsraelManagement of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery.Overcoming aspirin treatment failure in diabetes.Adherence to dual antiplatelet therapy: can we do better?Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials.Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1).Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry.Impact of income status on prognosis of acute coronary syndrome patients during Greek financial crisis.Effect of acute coronary syndrome patients' education on adherence to dual antiplatelet therapy.Effect of sex difference in clinical presentation (stable coronary artery disease vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on 2-year outcomes in patients undergoing percutaneous corDuration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study.Major bleeding risk prediction using Chronic Kidney Disease Epidemiology Collaboration and Modification of Diet in Renal Disease equations in acute coronary syndrome.Pharmacodynamic effects of a new fixed-dose clopidogrel-aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial.
P2860
Q34055438-AFD38BA3-CCC0-47E8-B846-6C29876F5BEEQ34076164-73778DD9-E1C5-47DD-AC6B-C4D76FAFCF7DQ34728842-9BD89E26-AB97-4CE8-929F-CB1AE47C513CQ35680854-EDB782C2-2461-4DA6-A1DF-C809ECAF2623Q35878084-EF8BFD3A-56CB-43BA-8E4F-E2992DA469F2Q35922517-8DF66367-526F-41BA-BF18-2DCE75E5E439Q36143090-2CC7C73A-5646-455B-A27B-0FB6B8D47757Q36645771-CAD0446F-6D5E-4D2D-9FC2-E9D84C07B602Q37134004-DA092E38-7669-4949-8575-6D0923AE0291Q37355978-03948499-727C-4934-AA16-E748D08D8C58Q37606698-6C79F952-1632-4C10-8741-05D4763CBFE7Q37648458-993848CC-330F-4F37-BE93-16053605598AQ37711266-12ABF44D-4227-462D-938F-3D1BF45279E0Q37912273-7214FFCD-5E3B-4B12-8033-A3DFC1F17B0DQ38055245-0F0F80D3-2127-4699-948D-8003B2A747D4Q38153790-6AA52FEB-7681-4C56-BC27-D540AC50DB83Q38817051-20E5464D-5753-457D-88DA-4A96EABC843DQ39963040-2D4C7E6B-7D5C-4290-BD26-F54F608DCC5EQ40655340-82D8517A-753D-40ED-A020-DA1491784B13Q41057117-86F38878-C07A-4231-A012-CDADA628758FQ42137897-1A05BC03-A769-4805-9EB5-ED864237261AQ47612318-6156AA02-0E27-4DAE-9E08-0BCB1168BCD0Q47770339-5BC37359-56DC-47C5-9B19-6DAC0DC56F90Q50961980-7D27F33C-2E96-41DE-87E3-4E6BBC94E701Q51185270-0B5DE6D2-7E97-4C5F-8429-4E118CFF2180
P2860
Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Background, incidence, and pre ...... ug-eluting stent implantation.
@en
Background, incidence, and pre ...... ug-eluting stent implantation.
@nl
type
label
Background, incidence, and pre ...... ug-eluting stent implantation.
@en
Background, incidence, and pre ...... ug-eluting stent implantation.
@nl
prefLabel
Background, incidence, and pre ...... ug-eluting stent implantation.
@en
Background, incidence, and pre ...... ug-eluting stent implantation.
@nl
P2093
P1433
P1476
Background, incidence, and pre ...... ug-eluting stent implantation.
@en
P2093
Andrés Iñiguez
Beth Pujol
Bruno García-Del Blanco
Dario Sanmiguel
David García-Dorado
Fernando Alfonso
Gaietà Permanyer-Miralda
Gerard Martí
Ignacio Ferreira-González
Joaquín Sánchez-Gila
P304
P356
10.1161/CIRCULATIONAHA.110.938290
P407
P50
P577
2010-08-23T00:00:00Z